Nephropathic Cystinosis. Posterior Segment Manifestations and Effects of Cysteamine Therapy

Ophthalmology

Volumn 113, Issue 6, 2006, Pages 1002-1009

  Tsilou, Ekaterini T ^a   Rubin, Benjamin I ^a   Reed, George ^a   Caruso, Rafael C ^a   Iwata, Fumino ^b   Balog, Joan ^c   Gahl, William A ^d   Kaiser Kupfer, Muriel I ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTAMINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTINOSIS; DRUG EFFECT; ELECTROPHYSIOLOGY; ELECTRORETINOGRAPHY; EYE DISEASE; FEMALE; HUMAN; INFANCY; MAJOR CLINICAL STUDY; MALE; PERIMETRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA; RETINOPATHY; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELD;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTEAMINE; CYSTINOSIS; ELECTRORETINOGRAPHY; FEMALE; HUMANS; INFANT; MALE; RETINA; RETINAL DISEASES; VISUAL ACUITY; VISUAL FIELDS;

EID: 33646942145     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2005.12.026     Document Type: Article

References (30)

1. Gahl W.A., Thoene J.G., and Schneider J.A. Cystinosis. a disorder of lysosomal membrane transport. In: Scriver C.R., Beaudet A.L., Valle D., et al. (Eds). The Metabolic and Molecular Bases of Inherited Disease. Vol. 3. 8th ed (2001), McGraw-Hill, New York 5085-5108
2. Gahl W.A., Thoene J.G., and Schneider J.A. Cystinosis. N Engl J Med 347 (2002) 111-121
3. Town M., Jean G., Cherqui S., et al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 18 (1998) 319-324
4. Gahl W.A., Bashan N., Tietze F., et al. Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science 217 (1982) 1263-1265
5. Kalatzis V., Cherqui S., Antignac C., and Gasnier B. Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. EMBO J 20 (2001) 5940-5949
6. Gahl W.A., Kuehl E.M., Iwata F., et al. Corneal crystals in nephropathic cystinosis. natural history and treatment with cysteamine eyedrops. Mol Genet Metab 71 (2000) 100-120
7. Wong V.G., Lietman P.S., and Seegmiller J.E. Alterations of pigment epithelium in cystinosis. Arch Ophthalmol 77 (1967) 361-369
8. Thoene J.G., Oshima R.G., Crawhall J.C., et al. Cystinosis. intracellular cystine depletion by aminothiols in vitro and in vivo. J Clin Invest 58 (1976) 180-189
9. Gahl W.A., Tietze F., Butler J.D., and Schulman J.D. Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulfide interchange. Biochem J 228 (1985) 545-550
10. Gahl W.A., Reed G.F., Thoene J.G., et al. Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 316 (1987) 971-977
11. Markello T.C., Bernardini I.M., and Gahl W.A. Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 328 (1993) 1157-1162
12. Marmor M.F., Zrenner E., and International Society for Clinical Electrophysiology of Vision. Standard for clinical electroretinography (1999 update). Doc Ophthalmol 97 (1998) 143-156
13. Andreasson S.O., Sandberg M.A., and Berson E.L. Narrow-band filtering for monitoring low-amplitude cone electroretinograms in retinitis pigmentosa. Am J Ophthalmol 105 (1988) 500-503
14. Anikster Y., Lucero C., Guo J., et al. Ocular, nonnephropathic cystinosis. clinical, biochemical and molecular correlations. Pediatr Res 47 (2000) 17-23
15. Shotelersuk V., Larson D., Anikster Y., et al. CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet 63 (1998) 1352-1362
16. Kaiser-Kupfer M.I., Caruso R.C., Minckler D.S., and Gahl W.A. Long-term ocular manifestations in nephropathic cystinosis. Arch Ophthalmol 104 (1986) 706-711
17. Read J., Goldberg M.F., Fishman G., and Rosenthal I. Nephropathic cystinosis. Am J Ophthalmol 76 (1973) 791-796
18. Tsilou E.T., Rubin B.I., Reed G.F., et al. Age-related prevalence of anterior segment complications in patients with infantile nephropathic cystinosis. Cornea 21 (2002) 173-176
19. Yamamoto G.K., Schulman J.D., Schneider J.A., and Wong V.G. Long-term ocular changes in cystinosis. observations in renal transplant recipients. J Pediatr Ophthalmol Strabismus 16 (1979) 21-25
20. Dufier J.L., Dhermy P., Gubler M.C., et al. Ocular changes in long-term evolution of infantile cystinosis. Ophthalmic Paediatr Genet 8 (1987) 131-137
21. Richler M., Milot J., Quigley M., and O'Regan S. Ocular manifestations of nephropathic cystinosis. The French-Canadian experience in a genetically homogeneous population. Arch Ophthalmol 109 (1991) 359-362
22. Dureau P., Broyer M., and Dufier J.L. Evolution of ocular manifestations in nephropathic cystinosis. a long-term study of a population treated with cysteamine. J Pediatr Ophthalmol Strabismus 40 (2003) 142-146
23. Francois J., Hanssens M., Coppieters R., and Evens L. Cystinosis. A clinical and histopathologic study. Am J Ophthalmol 73 (1972) 643-650
24. Park M., Helip-Wooley A., and Thoene J. Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells. J Am Soc Nephrol 13 (2002) 2878-2887
25. Park M.A., and Thoene J.G. Potential role of apoptosis in development of the cystinotic phenotype. Pediatr Nephrol 20 (2005) 441-446
26. Kimonis V.E., Troendle J., Rose S.R., et al. Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab 80 (1995) 3257-3261
27. Gahl W.A., Charnas L., Markello T.C., et al. Parenchymal organ cystine depletion with long-term cysteamine therapy. Biochem Med Metab Biol 48 (1992) 275-285
28. Sonies B.C., Almajid P., Kleta R., et al. Swallowing dysfunction in 101 patients with nephropathic cystinosis. benefit of long-term cysteamine therapy. Medicine (Baltimore) 84 (2005) 137-146
29. Kaiser-Kupfer M.I., Fujikawa L., Kuwabara T., et al. Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. N Engl J Med 316 (1987) 775-779
30. Kaiser-Kupfer M.I., Gazzo M.A., Datiles M.B., et al. A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis. Arch Ophthalmol 108 (1990) 689-693